US 10292971
Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs
granted A61KA61K31/437A61K31/4545
Quick answer
US patent 10292971 (Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs) held by Olema Pharmaceuticals, Inc. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Olema Pharmaceuticals, Inc.
- Grant date
- Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/437, A61K31/4545, A61K31/475, A61K31/506